SRZN – surrozen, inc. (US:NASDAQ)

News

Surrozen to Present at Upcoming Healthcare Investor Conferences
Surrozen Provides Third Quarter 2024 Financial Results and Business Update
Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-ß Antibodies for Idiopathic Pulmonary Fibrosis [Yahoo! Finance]
Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-ß Antibodies for Idiopathic Pulmonary Fibrosis
Surrozen earns $10M milestone payment through Boehringer collaboration [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com